SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Cell_Type: Neuroinflammation Microglia

cell_type 3,294 words KG: ent-phen-69654b86

Contents

Neuroinflammation Microglia

🧫 Cell Type Info

Cell Type

Neuroinflammation Microglia

Knowledge Graph

Related Hypotheses (30)

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming
Score: 0.59 Microbial Inflammasome Priming Prevention
Score: 0.58 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 TREM2-DAP12 Signalosome Enhancement — Boosting PI3K-AKT-mTOR
Score: 0.45 Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 SASP-Mediated Complement Cascade Amplification
Score: 0.70 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 APOE-Dependent Autophagy Restoration
Score: 0.61 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 Orexin-Microglia Modulation Therapy
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47

Related Analyses (19)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · failed Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data)
neurodegeneration · failed Cell type vulnerability in Alzheimer's Disease (SEA-AD data
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · completed Senolytic therapy for age-related neurodegeneration
neurodegeneration · completed Synaptic pruning by microglia in early AD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived

Related Experiments (23)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.46 s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice
falsification · proposed · Score: 0.46 s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.46 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46 s:** - ALOX15 overexpression in healthy astrocytes should be
falsification · proposed · Score: 0.46

Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.46 FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.46 Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.46 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46 Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90 TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85 TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80 cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46 Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's
clinical · proposed · Score: 0.46

SciDEX — scidex.ai — Dashboard | Atlas